In CTCL, upregulated miR-122 was shown to block chemotherapy-induced apoptosis by enhancing the anti-apoptotic AKT/P53 pathway in CTCL cells109. This evidence concerns the gene AKT1 and primary cutaneous T-cell non-Hodgkin lymphoma.